
CAS 2484719-14-2
:Pyridine, 3-(3-ethoxyandrosta-5,16-dien-17-yl)-
Description:
Pyridine, 3-(3-ethoxyandrosta-5,16-dien-17-yl)-, identified by its CAS number 2484719-14-2, is a chemical compound that features a pyridine ring substituted with an ethoxy group and an androstane derivative. Pyridine itself is a six-membered aromatic heterocycle containing one nitrogen atom, which imparts basic properties to the compound. The presence of the androstane moiety suggests that this substance may exhibit biological activity, potentially influencing hormonal pathways due to its steroid-like structure. The ethoxy group enhances the lipophilicity of the molecule, which may affect its solubility and permeability in biological systems. This compound may be of interest in medicinal chemistry and pharmacology, particularly in the development of steroid-based therapeutics. Its specific characteristics, such as melting point, boiling point, and reactivity, would depend on the detailed molecular structure and the interactions of its functional groups. Further studies would be necessary to elucidate its full chemical behavior and potential applications.
Formula:C26H35NO
Synonyms:- Pyridine, 3-(3-ethoxyandrosta-5,16-dien-17-yl)-
- Abiraterone impurities427
- Abiraterone Ethyl Ether
- Abiraterone Ethyl Ether Q: What is the CAS Number of
- Abiraterone Impurity 09
- Abiraterone Ethyl EtherQ: What is
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 5 products.
Abiraterone Ethyl Ether (3-((3S,8R,9S,10R,13S,14S)-3-ethoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C26H35NOColor and Shape:Off-White SolidMolecular weight:377.27186Abiraterone Ethyl Ether
CAS:Controlled Product<p>Applications Abiraterone Ethyl Ether is an impurity of Abiraterone (A108490), a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.<br>References Denis, L., et al.: Cancer, 72, 3888 (1993); Potter, G.A., et al.: J. Med. Chem., 38, 2463 (1995); Denmeade, S., et al.: Nat. Rev., 2, 389(2002); Scher, H., et al.: J. Clin. Oncol., 23, 8253 (2005)<br></p>Formula:C26H35NOColor and Shape:NeatMolecular weight:377.56Abiraterone Ethyl Ether-d5
CAS:Controlled Product<p>Applications Abiraterone Ethyl Ether-d5 is the labeled analogue of Abiraterone Ethyl Ether (A108525), an impurity of Abiraterone (A108490), a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.<br>References Denis, L., et al.: Cancer, 72, 3888 (1993); Potter, G.A., et al.: J. Med. Chem., 38, 2463 (1995); Denmeade, S., et al.: Nat. Rev., 2, 389(2002); Scher, H., et al.: J. Clin. Oncol., 23, 8253 (2005)<br></p>Formula:C26H30D5NOColor and Shape:NeatMolecular weight:382.59




